v3.25.1
Equity-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity of Options Granted Under the Plan
The table below presents the activity of the Company's stock options for the three months ended March 31, 2025:
Number of
stock options		Weighted
average
exercise price per
stock option		Weighted
average
 remaining
contractual
term (in years)		Aggregate
intrinsic value
(in $ millions)
Balance as of December 31, 202413,338,391$7.52 
Exercised (3,348,336)$5.86 
Expired
(60,777)$10.03 
Balance as of March 31, 20259,929,278$8.06 
Exercisable as of March 31, 20259,929,278$8.06 3.5$4 
Schedule of Activity of RSUs Granted Under the 2022 Plan
The table below presents the activity of the Company’s RSUs for the three months ended March 31, 2025:
Number of RSUs Weighted
average grant
date fair value
Balance as of December 31, 202425,410,910$6.17 
Granted6,228,922$8.52 
Forfeited(280,498)$5.92 
Vested (11,387,027)$6.39 
Balance as of March 31, 202519,972,307$6.78 
Schedule of Equity-based Compensation Expense Recognized in Consolidated Statements of Operations
Total equity-based compensation expense recognized in the Company’s consolidated statements of operations for the three months ended March 31, 2025 and 2024 amount to $19 million and $18 million, respectively ($15 million and $14 million, net of taxes, respectively) and were included as follows:
(in $ millions)Three months ended March 31,
20252024
Cost of revenue (excluding depreciation and amortization)$1 $1 
Sales and marketing 5 4 
Technology and content5 4 
General and administrative8 9 
Total$19 $18